Replimune (REPL) Depreciation and Depletion (2020 - 2024)
Replimune (REPL) posted Depreciation and Depletion of $700000.0 for Q2 2024, little changed sequentially from $700000.0 in Q4 2023, and up 16.67% YoY from $600000.0 in Q3 2023.
Replimune (REPL) Depreciation and Depletion (2020 - 2024) Analysis & Trends
Replimune has reported Depreciation and Depletion for 5 years, with the latest figure at $700000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Replimune | 1.24 Bn | 1.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 600,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 620,000.00 |
| Jun 30, 2022 | 620,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Sep 30, 2021 | 532,000.00 |
| Sep 30, 2021 | 532,000.00 |
| Jun 30, 2021 | 518,000.00 |
| Jun 30, 2021 | 518,000.00 |